1. Liver carnitine acyltransferase activities with palmitoyl-CoA and octanoyl-CoA as substrates and heart carnitine palmitoyltransferase were measured as overt activities in whole mitochondria or in mitochondria disrupted by sonication or detergent treatment.
All measurements were made in sucrose/KCl-based media of 300mosmol/litre. 2. In liver mitochondria, acyltransferase measured with octanoyl-CoA, like carnitine palmitoyltransferase, was found to have latent and overt activities. 3. Liver acyltransferase activities measured with octanoyl-CoA and palmitoyl-CoA differed in their response to changes in [K+l, Triton X-100 treatment and, in particular, in their response to Mg2+. Mg2+ stimulated activity with octanoyl-CoA, but inhibited carnitine palmitoyltransferase. 4. The effects of K+ and Mg2+ on liver overt carnitine palmitoyltransferase activity were abolished by Triton X-100 treatment. 5. Heart overt carnitine palmitoyltransferase activity differed from the corresponding activity in liver in that it was more sensitive to changes in [K+] and was stimulated by Mg2+. Heart had less latent camitine palmitoyltransferase activity than did liver. 6. Overt carnitine palmitoyltransferase in heart mitochondria was extremely sensitive to inhibition by malonyl-CoA. Triton X-100 abolished the effect of low concentrations of malonyl-CoA on this activity. 7. The inhibitory effect of malonyl-CoA on heart carnitine palmitoyltransferase could be overcome by increasing the concentration of palmitoylCoA.
The system for transfer of long-chain fatty acid units across the mitochondrial inner membrane appears to require two pools of long-chain carnitine acyltransferase (CPT) (Fritz & Yue, 1963; Yates & Garland, 1970; Hoppel & Tomec, 1972; Harano et al., 1972; Brosnan et al., 1973) , one of which is latent and the other overt in intact mitochondria. Generally, studies of the degree of latency of this activity have been confined to liver mitochondria. There is also evidence for the existence of a distinct medium-chain carnitine acyltransferase activity (COT) in liver and heart mitochondria (Kopec & Fritz, 1971; Solberg, 1971) . The physiological role of this activity is unknown, and it has not been investigated whether this activity also shows latency. More recently, as a result of the finding that Abbreviations used: COT, carnitine acyltransferase activity with octanoyl-CoA; CPT, carnitine palmitoyltransferase (EC 2.3.1.21); Nbs2, 5,5'-dithiobis-(2-nitrobenzoic acid).
malonyl-CoA is a potent inhibitor of the overt form of CPT in liver mitochondria from fed rats (see review by McGarry & Foster, 1980) , there has been renewed interest in the properties and control of carnitine acyltransferase. This effect has assumed particular importance in the control of ketogenesis (McGarry & Foster, 1980) . At the outset of the present study it was thought to be of interest to investigate the effect of malonyl-CoA on CPT activity in mitochondria from the heart, a tissue which is regarded as having little lipogenic or ketogenic capacity, although it is active in fatty acid oxidation. Some findings from these studies are presented, together with several other observations which arose from experiments preliminary to the above study. In essence these show that liver and heart overt CPT and liver COT activities are considerably affected by various metal ions, that these ionic effects differ for each activity and also that these activities differ somewhat in the extent of Materials and methods Animals These were Sprague-Dawley rats weighing 160-180g, bred in the Animal Colony at University College London, and maintained on GR3-EK cube diet (E. Dixon and Sons, Ware,-Herts., U.K.).
Chemicals
Palmitoyl-CoA, octanoyl-CoA, malonyl-CoA and acetyl-CoA were from International Enzymes Ltd. (Windsor, Berks., U.K.). Triton X-100, L-carnitine hydrochloride, NbS2 and bovine plasma albumin (fraction V)were from Sigma (London) Chemical Co.
(Kingston-upon-Thames, Surrey, U.K.). Before use the albumin was subjected to a defatting procedure (Chen, 1967) with minor modifications (Saggerson, 1972 Radiochemical Centre (Amersham, Bucks., U.K.).
Isolation ofmitochondria
All operations were at 0-20C. Liver from a single rat or the hearts of four to six rats were collected in .0.25M-sucrose medium containing 10mM-Tris/HCI, pH 7.4, and 1 mM-EGTA. These were finely chopped with scissors, washed to remove blood and homogenized in the same medium containing, in addition, fatty acid-poor albumin (lOmg/ml). This was done with three or four strokes of a motor-driven Teflon pestle in a glass Potter/Elvehjem homogenizer (radial clearance 0.19mm). The volume of the homogenate was adjusted in the proportion 10ml of sucrose/albumin medium per g wet wt. of tissue. Centrifugation conditions for isolation and washing of the mitochondria were as described by Harper & Saggerson (1975) . The mitochondrial pellets were washed once with 0.25 M-sucrose/lOmM-Tris/HCl (pH 7.4)/i mM-EGTA. Finally, the mitochondria were resuspended in 0.3M-sucrose/10mM-Tris/HCl (pH 7.4)/1 mM-EGTA (2 or 4 ml of medium per g of original tissue for heart or liver mitochondria respectively). The protein contents of these stock mitochondrial suspensions, determined by the method of Lowry et al. (1951) (see below) . Throughout, the values presented refer to the steady rates that were finally obtained after these lags. These rates of change in A412 were proportional to mitochondrial concentration.
For the radiochemical assay, mitochondria were preincubated for 3-4min at 250C with the reaction mixture before initiation of the reaction by addition of 2Ou1 of water containing 400nmol of Lcarnitine + luCi of DL-[methyl-3Hlcarnitine. The reaction was terminated after 4 min. During this time the reaction was proportional to mitochondrial concentration and was linear with time. Zero-time blanks were subtracted from all experimental values. The reaction was monitored by measurement of 3H incorporation either into acid-insoluble products or into butanol-soluble products. These two methods gave very similar results. For measurement of acid-precipitated palmitoylcarnitine, the reaction was stopped by addition of 1.0ml of ice-cold 0.6 M-trichloroacetic acid followed by transfer of the assay tube into ice. After addition of 5 ml of 0.3 M-trichloroacetic acid, the tube contents were filtered under suction through a Millipore filter (0.45,um pore size). The tube was washed with 5 ml of 0.3 M-trichloroacetic acid, which was also applied to the filter, followed by a final washing of the filter with 5 ml of 0.3 M-trichloroacetic acid. The filter was dissolved in 10ml of scintillation fluid, consisting of 80g of naphthalene + 4 g of 2,5-bis-(5-t-butylbenzoxazol-2-yl)thiophen per litre of toluene/2-methoxyethanol (3:2, v/v). For measurement of radioactivity in butanol-soluble palmitoylcarnitine, the CPT reaction was stopped by addition of 1.0ml of ice-cold 1.2M-HCI followed by 2.0ml of watersaturated butanol. After mixing and brief centrifugation, the resulting butanol layer was washed with 5 ml of butanol-saturated water and 1.0ml of this taken for scintillation counting in 10ml of toluene containing 2,5-bis-(5-t-butylbenzoxazol-2-yl)-thiophen (4 g/litre). COT activity was measured in the Nbs2-linked assay or the radiochemical assay (by using butanol extraction of the product) used for CPT, except that octanoyl-CoA was substituted for palmitoyl-CoA. Lag periods with low [K+1 were not seen in the COT assay.
Citrate synthase (EC 4 Fig. 4 shows that K+ up to 60-80 mm increased overt heart CPT activity, but at higher KCI concentrations the activity was diminished. The effect of K+ on heart CPT was considerably greater than the effect of this ion on liver CPT (compare Figs. 2 and 4) .
These effects (Figs. 2-4) were not specific to K+ or Cl-, since both NaCl and potassium methanesulphonate had similar stimulatory/inhibitory effects on liver CPT and COT and on heart CPT (results not shown).
Overt liver CPT activity was decreased by Mg2+ in the presence of 40mM-K+ (Fig. 5) , in the absence of K+ (Table 3) 2.5 mM-MgCl2 increased heart CPT by approx. 50% and 0.25 mM-MnCl2 also slightly stimulated CPT (Fig. 6) . In this Nbs2-linked assay, higher concentrations of Mg2+, or particularly Mn2+, were inhibitory (Fig. 6) . Other experiments, with the radiochemical assay (results not shown), indicated that these inhibitory effects of higher concentrations of Mg2+ or Mn2+ on overt heart CPT were only seen when Nbs2 was present.
Liver overt COT activity, unlike liver CPT, but like heart CPT, was increased by Mg2+ (Figs. 3 and 5,  Table 3 ). This effect was most pronounced at zero [K+] (Fig. 3, Table 3 ). The effects of K+ and Mg2+ on COT appeared to be mutually exclusive in that no Mg2+ effect was seen in the presence of high [K+I and no stimulatory effect of K+ was seen in the presence of Mg2+. Mg2+ has similar effects on the total COT obtained on sonication of the mitochondria (Fig. 3) , and it may be calculated that Mg2+ causes a small increase in the latent COT activity over the [K+] range of 0-90mM. Fig. S and Table 3 show that the effects of Mg2+ and K+ on hepatic CPT are lost on treatment of the mitochondria with Triton X-100 (0.4mg/ml). This detergent concentration was used since it was the lowest that totally abolishes the effect of Mg2+ (Fig.  7) and, on addition to the assay mixtures, appeared satisfactorily to disrupt or dissolve much of the mitochondria, rapidly resulting in stable assay conditions. As a consequence of the loss of ionic effects in the presence of detergent, the apparent ratio of latent/overt hepatic CPT activity is very dependent on the ionic conditions used for measure- Table 3 and Fig. 2) . Table 3 shows that the effect of Triton X-100 on hepatic COT activity was also dependent on the ionic composition of the assays and clearly differed from the effect of the detergent on the hepatic CPT assay. Whereas the relative effect of the detergent to increase the measured CPT was greatest in the presence of Mg2+, the opposite was found for the COT activity.
With the Nbs2-linked assay with 0-100mM-K+, sonication or treatment with Triton X-100 (at an optimum concentration of 0.4 mg/ml) gave little increase in heart CPT activity over that seen with whole mitochondria (Fig. 4) . In some instances increases in activity of up to 50% were observed after sonication and assay with 40mM-K+. Effects of Triton X-100 were rather variable, sometimes giving small increases and sometimes small decreases in heart CPT activity. With the radiochemical assay for CPT (Table 4) it was also shown that this apparent lack of an extensive latent CPT activity cannot be attributed to the presence of Nbs2 in assays (at 60mM-K+). Essentially the same results are obtained if the radiochemical assay is used with sonicated mitochondria with or without 0.5 mmdithiothreitol for thiol-group protection (results not shown). It is therefore concluded either that a relatively large proportion of the total CPT activity in heart mitochondria is overt or that none of the range of assay conditions employed adequately measure the latent activity. Table 4 shows that the effect of high [K+] to inhibit CPT is dependent on the presence of Nbs2 (or that inhibitory effects of Nbs2 are dependent on high ion concentrations). In the presence of Triton X-100, CPT was less subject to inhibition by high [K+] (see Fig. 4 ), or alternatively Triton X-100 protected against inhibitory effects of Nbs2 which are enhanced when [K+] is raised.
In summary, it is shown that the three carnitine acyltransferase activities measured here are influenced considerably, but differently, by the ionic composition of assay media. In turn, the extent of these effects may be influenced by the type of assay used. At present it is not established whether these ions affect the activity of enzymes directly or do this indirectly by first perturbing membrane structure. In this respect it is noteworthy that Triton treatment abolished ionic effects on hepatic CPT. Furthermore, the inhibitory effect of malonyl-CoA on hepatic CPT is also lost on release of the enzyme from membrane association (McGarry et al., 1978) . It is likely that it is necessary to study the regulation of these activities in situ in mitochondria or at least in association with membrane structures. The findings presented here may be pertinent to such studies. Effect ofmalonyl-CoA on heart mitochondria With the Nbs2-linked assay, it was found (Fig. 8 ) that heart overt CPT activity was extremely sensitive to inhibition by malonyl-CoA. The effect of this metabolite was seen in the presence and absence of Mg2+, and in both cases 50% inhibition was obtained with 1-2,uM-malonyl-CoA. By using similar Nbs2-linked assays with liver mitochondria from the same population of rats, at least 10-fold higher malonyl-CoA concentrations were needed to obtain the same degree of inhibition of CPT (results not shown). In the absence of Mg2+ a plot of 100 x (percentage inhibition of CPT)-' versus [malonyl-CoA'-l was linear (r = 0.999) with an intercept on the ordinate at 1.08, implying that 93% of the overt CPT activity could be inhibited by malonyl-CoA. In rat liver it has been concluded that only the overt form of CPT is sensitive to malonylCoA (McGarry et al., 1978) . Fig. 9 demonstrates that 5,uM-malonyl-CoA induced a considerable sigmoidicity into the relationship between CPT activity and palmitoyl-CoA concentration. In liver mitochondria, the inhibitory effect of malonyl-CoA appears to require association of CPT with membranes (McGarry et al., 1978) . Inclusion of Triton X-100 in the assay of heart CPT abolished the effect of 5,uM-malonyl-CoA (Fig. 9 ). After sonication or treatment of heart mitochondria with Triton X-100, considerable carnitine acetyltransferase activity was released. Commercial malonyl-CoA preparations appear to contain sufficient acetyl-CoA as a contaminant to make it impossible to investigate the effect of malonyl-CoA on CPT, measured by the Nbs2-linked assay, after mitochondrial disruption. The same problem, however, does not apply to the radiochemical assay of the enzyme. In an experiment using this assay, treatment of intact heart mitochondria with Triton X-100 (0.4 mg/ml) increased the measured CPT Palmitoyl-CoA (uM) Fig. 9 . Effect ofpalmitoyl-CoA on CPT activity in heart mitochondria Nbs2-linked assays were performed in the presence of 40 mM-K+ and 400,uM-L-carnitine either with whole mitochondria (0, 0) or with Triton X-100 (0.4mg/ml) added to the assays (0, *). The values are means + S.E.M. for three experiments. 0, *, with 5,uM-malonyl-CoA; 0, O, without malonyl-CoA. Triton, the corresponding inhibitions in response to these malonyl-CoA concentrations were 26 + 2% and 39 + 3% (means + S.E.M. for four experiments in each case). With intact mitochondria all the CPT activity was sedimentable by centrifugation for 2 min at 9000g., in an Eppendorf 5412 centrifuge. After 2 min of treatment with Triton X-100 (0.4 mg/ml) none of the CPT activity was then sedimentable by this treatment (results not shown). The implication is that 'solubilization' considerably decreases, but does not abolish, sensitivity of heart CPT to malonylCoA. The findings of Fig. 4 discussed above suggest that detergent treatment or sonication are unlikely to release large amounts of latent CPT, which, in liver, is suggested to be insensitive to malonyl-CoA (McGarry et al., 1978) .
In conclusion, heart mitochondria appear to contain a CPT activity that differs in sensitivity to metal ions and in relative proportions of latent and overt forms from that found in liver. The overt form of the heart enzyme shows a high sensitivity to inhibition by malonyl-CoA. The malonyl-CoA content in heart is not known. If malonyl-CoA is present to any extent in this tissue under any normal or pathological condition, it could constitute a potent regulator of cardiac fatty acid oxidation.
